Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study

Affiliations

• ¹ Center for Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, USA. nathan.gossai@childrensmn.org.
• ² Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
• ³ Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
• ⁴ Department of Pediatrics, Oregon Health and Science University, Portland, OR, USA.
• ⁵ Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
• ⁶ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
• ⁷ Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ⁸ Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
• ⁹ Division of Pediatric Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.